Carlos Blanco, MD, PhD

National Institute on Drug Abuse, Bethesda, Maryland

  • 52Articles
  • 264.4KReads
  • 2003–2026Active
  • 142Collaborators
  • 2.3KCitations

About

Carlos Blanco, MD, PhD, is affiliated with the National Institute on Drug Abuse in Bethesda, Maryland. With over two decades of publications since 2003, Blanco has contributed extensively to research on addiction, mood and anxiety disorders, posttraumatic stress disorder, suicide, bipolar disorder, and impulse-control disorders. The author’s work includes studies on benzodiazepine prescribing trends, defense mechanisms in psychiatric disorders, sex differences in antidepressant use, and the interplay between borderline personality disorder and PTSD. Blanco frequently collaborates with colleagues such as Mark Olfson and Nicolas Hoertel, publishing in Psychiatrist.com journals.

Publications

JCP
Trends in Benzodiazepine Prescribing to Adults in the United States
Original Research

Trends in Benzodiazepine Prescribing to Adults in the United States

February 18, 2026

Between 2018 and 2022, annual benzodiazepine use by US adults decreased from 4.7% to 3.4%.
, , , et al
JCP
Defense Mechanisms and Common Psychiatric Disorders
Original Research

Defense Mechanisms and Common Psychiatric Disorders

April 28, 2025

Individuals with mood, anxiety, or substance use disorders generally had a higher prevalence of defense mechanisms than those with no disorders. Defense mechanisms and psychiatric disorders represent correlated but...
, , , et al
JCP
Sex Differences in Antidepressant Acceptability
Original Research

Sex Differences in Antidepressant Acceptability

December 4, 2024

This study provides evidence of sex differences in antidepressant acceptability, with fluoxetine more acceptable for men than women and the reverse true for paroxetine. Findings suggest the importance of...
, , , et al
JCP
Bridge Symptoms Between Borderline Personality and PTSD
Original Research

Bridge Symptoms Between Borderline Personality and PTSD

September 9, 2024

Self-aggression, feelings of emptiness, dissociation, and feelings of detachment were found to be bridge symptoms between borderline personality disorder and PTSD. Targeting these might allow better prevention and management...
, , , et al
JCP
Sleep Complaints and Risk of Psychiatric Disorders
Original Research

Sleep Complaints and Risk of Psychiatric Disorders

December 21, 2022

Sleep complaints were associated with risk of psychiatric disorders independent of sociodemographic and clinical characteristics in this study of NESARC data.
, , , et al
JCP
Acceptability of Second-Line Antidepressant Medications
Original Research

Acceptability of Second-Line Antidepressant Medications

October 17, 2022

Second-line antidepressant options were ranked according to acceptability (efficacy and tolerability), using data from the French health system.
, , , et al
JCP
Predictors of Recurrence or Persistence in Panic Disorder
Original Research

Predictors of Recurrence or Persistence in Panic Disorder

July 25, 2022

The heterogeneous course of panic disorder necessitates the development of a comprehensive predictive model of recurrence or persistence for these patients. This study sought to build such a model...
, , , et al
JCP
Original Research

Heterogeneity in the Timing of Suicide Attempt Onset

April 7, 2020

Research suggests substantial age differences in suicide and suicide attempt rates. To better understand this heterogeneity, this study compared psychiatric, family history, and sociodemographic characteristics among 4 suicide attempter...
, , , et al
JCP
Original Research

Model of Prescription Opioid Use Disorder

December 3, 2019

Prior research has identified several risk factors for prescription opioid use disorder (POUD). The authors attempted to develop a conceptual model for POUD based on an existing model for...
, , , et al
JCP
Original Research

Treatment of Common Mental Disorders in the US

May 28, 2019

When patients present for treatment of anxiety or mood disorders, do you consider whether there is also an untreated substance use disorder? Check out these data on disorder prevalence...
, , , et al
JCP
Original Research

Benzodiazepine Use, Misuse, and Use Disorders in the US

October 16, 2018

Benzodiazepines are used widely for anxiety and insomnia, but what proportion of users are misusing them? This analysis of National Surveys on Drug Use and Health data considers correlates...
, , , et al
JCP
Original Research

Aging, Psychiatric Disorders, and Suicide Attempt

October 9, 2018

Psychiatric disorders often co-occur, and comorbidity patterns as well as suicide risk vary across the lifespan. Read this article to learn if suicide attempt risk in older and younger...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe